We included peer-reviewed randomized controlled trials, meta-analyses, and high-quality narrative or systematic reviews written in English that evaluated the effects of GLP-1 receptor agonists (liraglutide, semaglutide, or related analogues), as well as dual GIP/GLP-1 receptor agonists (such as tirzepatide), exercise training, or their combination on weight loss, body composition, metabolic, or cardiovascular outcomes in adults with obesity or type 2 diabetes
72 More serious reactions are rare, but you should seek immediate medical attention if you develop hives, swelling of the lips, throat, or tongue, or difficulty breathing
IMPORTS The Largest Import Supplying Countries IMPORTS: HISTORICAL DATA (20122025) AND FORECAST (20262035) IMPORTS BY COUNTRY: HISTORICAL DATA (20122025) AND FORECAST (20262035) IMPORT PRICES BY COUNTRY: HISTORICAL DATA (20122025) AND FORECAST (20262035) 9
STEP Programme (Weight Management) The STEP clinical trials programme evaluated Semaglutide for weight management and demonstrated average body weight reduction of 14.9% with Semaglutide 2.4mg (Wegovy) in patients with obesity, paving the way for Wegovy approval for weight management
Frequently Asked Questions How long to stay on Retatrutide
